Finance

Lists
Why is 6472 up 2,88%?
Dive Deeper
6472:TPE
Bora Pharmaceuticals Co Ltd
428,50 NT$
+2,88%
(+12,00) 1D
7 ოქტ, 12:37:26 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6472...
Open
416,50 NT$
High
432,50 NT$
Low
416,00 NT$
Mkt. cap
54,86 მლრდ.
Avg. vol.
808,55 ათ.
Volume
479,63 ათ.
P/E ratio
35,16
52-wk high
693,00 NT$
52-wk low
330,50 NT$
EPS
12,19 NT$
No. of employees
36
Open
416,50 NT$
High
432,50 NT$
Low
416,00 NT$
Mkt. cap
54,86 მლრდ.
Avg. vol.
808,55 ათ.
Volume
479,63 ათ.
P/E ratio
35,16
52-wk high
693,00 NT$
52-wk low
330,50 NT$
EPS
12,19 NT$
No. of employees
36
News stories
From web sources and news partners
www.marketscreener.com
www.marketscreener.com
·
24 წუთის წინ
Diös and Mysafety trade ex-dividend on Nasdaq Stockholm today
Cryptonews.net
Cryptonews.net
·
1 საათის წინ
Winklevoss-backed Zcash ETF files with SEC for Nasdaq listing
Yahoo Finance
Yahoo Finance
·
1 საათის წინ
Strip Out AI and the S&P 500 Looks Very Different, Goldman Index Shows
CNBC
CNBC
·
7 საათის წინ
Chart: A look at the S&P 500's remarkable and defiant trip to a new record
About Bora Pharmaceuticals Co Ltd
CEOბობი შენგ
Employees36
Founded2007
Headquarters-
SectorPharmaceutical industry
Websitebora-corp.com
Last report
13 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (TWD)
4,24 NT$ / 5,73 NT$
-26,00%miss
Revenue / Est. (TWD)
5,89 მლრდ. / 5,55 მლრდ.
+6,10%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
4,81 მლრდ.
4,86 მლრდ.
4,00 მლრდ.
5,89 მლრდ.
Cost of goods sold
2,63 მლრდ.
3,09 მლრდ.
2,56 მლრდ.
3,46 მლრდ.
Cost of revenue
2,63 მლრდ.
3,09 მლრდ.
2,56 მლრდ.
3,46 მლრდ.
Research and development expenses
147,09 მლნ.
181,25 მლნ.
167,93 მლნ.
190,74 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
961,21 მლნ.
1,03 მლრდ.
866,09 მლნ.
1,25 მლრდ.
Operating expense
1,11 მლრდ.
1,22 მლრდ.
1,04 მლრდ.
1,44 მლრდ.
Total operating expenses
3,74 მლრდ.
4,30 მლრდ.
3,59 მლრდ.
4,90 მლრდ.
Operating income
1,06 მლრდ.
556,34 მლნ.
407,24 მლნ.
986,64 მლნ.
Other non operating income
36,54 მლნ.
15,19 მლნ.
24,01 მლნ.
-15,28 მლნ.
EBT including unusual items
895,42 მლნ.
809,67 მლნ.
221,15 მლნ.
813,10 მლნ.
EBT excluding unusual items
926,44 მლნ.
375,02 მლნ.
222,24 მლნ.
788,94 მლნ.
Income tax expense
73,70 მლნ.
381,93 მლნ.
174,25 მლნ.
205,59 მლნ.
Effective tax rate
8,23%
47,17%
78,79%
25,28%
Other operating expenses
396,00 ათ.
1,24 მლნ.
1,37 მლნ.
-
Net income
633,61 მლნ.
331,76 მლნ.
25,84 მლნ.
555,76 მლნ.
Net profit margin
13,18%
6,83%
0,65%
9,44%
Earnings per share
4,99
2,78
0,20
4,24
Interest and investment income
2,67 მლნ.
10,49 მლნ.
6,25 მლნ.
11,16 მლნ.
Interest expense
-125,12 მლნ.
-122,01 მლნ.
-113,73 მლნ.
-124,33 მლნ.
Net interest expenses
-122,44 მლნ.
-111,52 მლნ.
-107,48 მლნ.
-113,17 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,28 მლრდ.
784,95 მლნ.
634,54 მლნ.
1,27 მლრდ.
Gain or loss from assets sale
-10,15 მლნ.
1,32 მლნ.
63,00 ათ.
2,00 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები